Respiratory Care Devices

Respiratory Care Devices

Global Respiratory Care Devices Market to Reach US$28.5 Billion by 2030

The global market for Respiratory Care Devices estimated at US$19.1 Billion in the year 2023, is expected to reach US$28.5 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Therapeutic Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth in the Monitoring Devices segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.1 Billion While China is Forecast to Grow at 9.8% CAGR

The Respiratory Care Devices market in the U.S. is estimated at US$5.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Respiratory Care Devices Market - Key Trends and Drivers Summarized

The respiratory care devices market is experiencing robust growth, driven by increasing global incidences of chronic respiratory diseases such as COPD, asthma, and pulmonary hypertension, which are exacerbated by factors such as smoking, pollution, and aging populations. The rising elderly demographic, particularly vulnerable due to a natural decline in lung function, significantly contributes to the growing demand for these devices. This trend is supported by rising healthcare spending and enhancements in healthcare infrastructure, especially in emerging markets, which improve access to advanced respiratory care technologies. As a result, the need for devices that can diagnose, monitor, and treat respiratory conditions is expanding, ensuring ongoing management and care of these chronic ailments.

Technological advancements are propelling the respiratory care market forward, with the development of more efficient devices such as ventilators, nebulizers, and PAP devices that incorporate smart features for remote monitoring and patient management. The trend toward home healthcare is also accelerating demand for portable, user-friendly devices such as smart inhalers and portable spirometers, which enable patients to manage their conditions more autonomously. Integration with digital health platforms is enhancing this shift, allowing for better data collection and analysis, remote monitoring, and telehealth services, which promote proactive management of respiratory conditions and improve patient engagement and treatment adherence.

The future of respiratory care looks to be shaped significantly by the integration of AI and machine learning, which are poised to enhance the precision of treatment and early diagnosis. AI`s capability to analyze extensive data sets can predict treatment outcomes and patient adherence, potentially guiding more personalized and effective treatment strategies. Moreover, advanced sensors and e-health tools integrated into respiratory care devices are not only making treatments more adaptable to individual needs but are also predicting exacerbations, thereby reducing hospitalizations and improving overall patient quality of life. This shift towards more personalized, integrated, and technologically advanced respiratory care solutions is aligning with broader healthcare trends towards efficiency, patient-centered care, and cost-effectiveness.

Select Competitors (Total 13 Featured) -

• 3B Medical, Inc.
• Acare Technology Co., Ltd.
• Allied Healthcare Products, Inc.
• Becton, Dickinson and Company
• Chart Industries, Inc.
• Draegerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Corporation Ltd.
• Hamilton Medical AG
• Hill-Rom Holdings, Inc.
• Invacare Corporation
• Masimo Corporation
• Medline Industries, Inc.
• Medtronic PLC
• Philips India Ltd.
• ResMed Corporation
• Rotech Healthcare, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.